| Financial Year |
March 31 2023 |
| Monetary Funds |
2,890,932,911.89 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,750,003,194.14 |
| Advances to Suppliers |
91,975,435.25 |
| Other Receivables |
158,046,456.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
42,430,039.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,584,539.55 |
| Total Current Assets |
4,950,972,576.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,123,753,244.87 |
| Investment Properties |
19,201,909.09 |
| Fixed Assetes |
123,064,889,416.86 |
| Under-construction Projects |
24,277,955,482.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,224,462,435.03 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
25,583,238.09 |
| Deferred Income Tax Assets |
69,858,227.27 |
| Other Non-Current Assets |
907,751,842.48 |
| Sub-Total of Non-Current Assets |
159,706,991,641.37 |
| Total Assets |
164,657,964,218.26 |
| Short-Term Loans |
6,567,305,988.72 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
159,499,542.06 |
| Accounts Received In Advance |
345,516.69 |
| Employee Compensation Payable |
120,447,185.53 |
| Taxes Payable |
407,709,227.64 |
| Interest Payable |
-- |
| Dividend Payable |
285,511,835.63 |
| Other payables |
5,063,180,350.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,037,733,226.27 |
| Other Current Liabilities |
5,725,934,794.53 |
| Sub-Total of Current Liabilities |
26,082,155,832.18 |
| Long-term Loans |
67,502,212,290.34 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
40,714,448.09 |
| Special Payable |
-- |
| Estimatied Liabilities |
233,181,002.22 |
| Deferred Income Tax Liabilities |
101,021,185.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
67,986,928,354.05 |
| Total Liabilities |
94,069,084,186.23 |
| Paid-In Capital(Or Share Stock) |
18,000,000,000.00 |
| Capital Surplus |
18,836,601,711.88 |
| Surplus Reserve |
3,195,216,118.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
14,809,224,308.93 |
| Minority Stockholder's Interest |
2,150,037,489.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
68,438,842,542.51 |
| Owner's Equity（Stockholder's Equity） |
70,588,880,032.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
164,657,964,218.26 |
